Advanced search
Publication Cover
Free Radical Research Volume 52, 2018 - Issue 11-12: SFRR Asia
Submit an article Journal homepage
888
Views
16
CrossRef citations to date
0
Altmetric
Review Article

The role of decorin in cardiovascular diseases: more than just a decoration

Thu Thi VuFaculty of Biology, National Key Laboratory of Enzyme and Protein Technology, VNU University of Science, Hanoi, Vietnam; View further author information
,
Jubert MarquezNational Research Laboratory for Mitochondrial Signaling, Department of Physiology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; ;National Research Laboratory for Mitochondrial Signaling, Department of Health Sciences and Technology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; View further author information
,
Long Thanh LeNational Research Laboratory for Mitochondrial Signaling, Department of Physiology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; ;National Research Laboratory for Mitochondrial Signaling, Department of Health Sciences and Technology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; View further author information
,
Anh Thi Tuyet NguyenNational Research Laboratory for Mitochondrial Signaling, Department of Physiology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; ;National Research Laboratory for Mitochondrial Signaling, Department of Health Sciences and Technology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; View further author information
,
Hyoung Kyu KimNational Research Laboratory for Mitochondrial Signaling, Department of Physiology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; ;National Research Laboratory for Mitochondrial Signaling, Department of Health Sciences and Technology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; ;Department of Integrated Biomedical Science, College of Medicine, Inje University, Busan, KoreaCorrespondence[email protected] [email protected]
View further author information
&
Jin HanNational Research Laboratory for Mitochondrial Signaling, Department of Physiology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; ;National Research Laboratory for Mitochondrial Signaling, Department of Health Sciences and Technology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea; Correspondence[email protected] [email protected]
View further author information
Pages 1210-1219 | Received 23 Jan 2018, Accepted 22 Aug 2018, Published online: 23 Nov 2018

  • Fransson LA, Belting M, Jönsson M, et al. Biosynthesis of decorin and glypican. Matrix Biol. 2000;19(4):367–376.
  • Schaefer L, Iozzo RV. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem. 2008;283(31):21305–21309.
  • Chen S, Birk DE. Focus on molecules: decorin. Exp Eye Res. 2011;92(6):444–445.
  • Weis SM, Zimmerman SD, Shah M, et al. A role for decorin in the remodeling of myocardial infarction. Matrix Biol. 2005;24(4):313–324.
  • Yan W, Wang P, Zhao CX, et al. Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38 mitogen-activated protein kinase signaling pathways. Hum Gene Ther. 2009;20(10):1190–1200.
  • Seidler DG, Mohamed NA, Bocian C, et al. The role for decorin in delayed-type hypersensitivity. J Immunol. 2011;187(11):6108–6119.
  • Lai J, Chen F, Chen J, et al. Overexpression of decorin promoted angiogenesis in diabetic cardiomyopathy via IGF1R-AKT-VEGF signaling. Sci Rep. 2017;7:44473.
  • Santra M, Reed CC, Iozzo RV. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem. 2002;277(38):35671–35681.
  • Iozzo RV, Moscatello DK, McQuillan DJ, et al. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem. 1999;274(8):4489–4492.
  • Neill T, Painter H, Buraschi S, et al. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem. 2012;287(8):5492–5506.
  • Iozzo RV, Buraschi S, Genua M, et al. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem. 2011;286(40):34712–34721.
  • Csordás G, Santra M, Reed CC, et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem. 2000;275(42):32879–32887.
  • Neill T, Schaefer L, Iozzo RV. Decorin: a guardian from the matrix. Am J Pathol. 2012;181(2):380–387.
  • Mauviel A, Korang K, Santra M, et al. Identification of a bimodal regulatory element encompassing a canonical AP-1 binding site in the proximal promoter region of the human decorin gene. J Biol Chem. 1996;271(40):24824–24829.
  • Kanzler S, Lohse AW, Keil A, et al. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol. 1999;276(4 Pt 1):G1059–G1068.
  • Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990;346(6281):281–284.
  • Bianco P, Fisher LW, Young MF, et al. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem. 1990;38(11):1549–1563.
  • Weber IT, Harrison RW, Iozzo RV. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem. 1996;271(50):31767–31770.
  • Li Y, Li J, Zhu J, et al. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther. 2007;15(9):1616–1622.
  • Lin J, Wu H, Tarr PT, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 2002;418(6899):797–801.
  • Isaka Y, Brees DK, Ikegaya K, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med. 1996;2(4):418–423.
  • Border WA, Ruoslahti E. Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis. Cell Differ Dev. 1990;32(3):425–431.
  • Zhao J, Sime PJ, Bringas P, et al. Adenovirus-mediated decorin gene transfer prevents TGF-β-induced inhibition of lung morphogenesis. Am J Physiol. 1999;277(2 Pt 1):L412–LL422.
  • Mauviel A, Santra M, Chen YQ, et al. Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha. J Biol Chem. 1995;270(19):11692–11700.
  • Beanes SR, Dang C, Soo C, et al. Down-regulation of decorin, a transforming growth factor–beta modulator, is associated with scarless fetal wound healing. J Pediatr Surg. 2001;36(11):1666–1671.
  • Edwards IJ, Xu H, Wright MJ, et al. Interleukin-1 upregulates decorin production by arterial smooth muscle cells. Arterioscler Thromb. 1994;14(7):1032–1039.
  • Kuroda K, Shinkai H. Downregulation of decorin expression in dermal fibroblasts by interleukin-4. Arch Dermatol Res. 1997;289(8):476–480.
  • Strazynski M, Eble JA, Kresse H, et al. Interleukin (IL)-6 and IL-10 induce decorin mRNA in endothelial cells, but interaction with fibrillar collagen is essential for its translation. J Biol Chem. 2004;279(20):21266–21270.
  • Mogyorosi A, Ziyadeh FN. Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol. 1998;275(5 Pt 2):F827–F832.
  • Kähäri VM, Häkkinen L, Westermarck J, et al. Differential regulation of decorin and biglycan gene expression by dexamethasone and retinoic acid in cultured human skin fibroblasts. J Invest Dermatol. 1995;104(4):503–508.
  • Cabello-Verrugio C, Brandan E. A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. J Biol Chem. 2007;282(26):18842–18850.
  • Abdel-Wahab N, Wicks SJ, Mason RM, et al. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240. Biochem J. 2002;362(Pt 3):643–649.
  • Järveläinen H, Sainio A, Wight TN. Pivotal role for decorin in angiogenesis. Matrix Biol. 2015;43:15–26.
  • Shen J, Xia W, Khotskaya YB, et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature. 2013;497(7449):383–387.
  • Grant DS, Yenisey C, Rose RW, et al. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene. 2002;21(31):4765–4777.
  • Lala N, Girish GV, Cloutier-Bosworth A, et al. Mechanisms in decorin regulation of vascular endothelial growth factor-induced human trophoblast migration and acquisition of endothelial phenotype. Biol Reprod. 2012;87(3):59.
  • Piantadosi CA. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med. 2008;45(5):562–569.
  • Saretzki G. Telomerase, mitochondria and oxidative stress. Exp Gerontol. 2009;44(8):485–492.
  • Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 2010;459(6):923–939.
  • Ott M, Gogvadze V, Orrenius S, et al. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12(5):913–922.
  • Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biol Med Sci. 2008;4(2):89–96.
  • Jeroudi MO, Hartley CJ, Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol. 1994;73(6):2B–7B.
  • Ryrfeldt A, Bannenberg G, Moldéus P. Free radicals and lung disease. Br Med Bull. 1993;49(3):588–603.
  • Víctor VM, Espulgues JV, Hernández-Mijares A, et al. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets. 2009;9(4):376–389.
  • Smith RA, Hartley RC, Cochemé HM, et al. Mitochondrial pharmacology. Trends Pharmacol Sci. 2012;33(6):341–352.
  • Sasaki M, Joh T. Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr. 2007;40(1):1–12.
  • Aon MA, Cortassa S, Akar FG, et al. From mitochondrial dynamics to arrhythmias. Int J Biochem Cell Biol. 2009;41(10):1940–1948.
  • Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011;435(2):297–312.
  • Camara AK, Lesnefsky EJ, Stowe DF. Potential therapeutic benefits of strategies directed to mitochondria. Antioxid Redox Signal. 2010;13(3):279–347.
  • Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 2011;333(6046):1109–1112.
  • Heller A, Brockhoff G, Goepferich A. Targeting drugs to mitochondria. Eur J Pharm Biopharm. 2012;82(1):1–18.
  • Armstrong JS. Mitochondria-directed therapeutics. Antioxid Redox Signal. 2008;10(3):575–578.
  • Neill T, Torres A, Buraschi S, et al. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) and mitostatin. J Biol Chem. 2014;289(8):4952–4968.
  • Schaefer L, Tredup C, Gubbiotti MA, et al. Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology. FEBS J. 2017;284(1):10–26.
  • Yan J, Stringer SE, Hamilton A, et al. Decorin GAG synthesis and TGF-beta signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2011;31(3):608–615.
  • Ferrini MG, Moon J, Rivera S, et al. Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-beta1 therapies in inducible nitric oxide synthase-deficient mice. BJU Int. 2012;109(4):586–593.
  • Abe Y, Sakairi T, Beeson C, et al. TGF-beta1 stimulates mitochondrial oxidative phosphorylation and generation of reactive oxygen species in cultured mouse podocytes, mediated in part by the mTOR pathway. Am J Physiol Renal Physiol. 2013;305(10):F1477–F1490.
  • Rhyu DY, Yang Y, Ha H, et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005;16(3):667–675.
  • Jain M, Rivera S, Monclus EA, et al. Mitochondrial reactive oxygen species regulate transforming growth factor-beta signaling. J Biol Chem. 2013;288(2):770–777.
  • Alan C, Kocoglu H, Altintas R, et al. Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney. Arch Med Sci. 2011;7(2):211–216.
  • Özay R, Türkoğlu E, Gürer B, et al. Does decorin protect neuronal tissue via its antioxidant and antiinflammatory activity from traumatic brain injury? An Experimental Study. World Neurosurg. 2017;97:407–415.
  • Thu VT, Kim HK, Long le T, et al. NecroX-5 exerts anti-inflammatory and anti-fibrotic effects via modulation of the TNFα/Dcn/TGFβ1/Smad2 pathway in hypoxia/reoxygenation-treated rat hearts. Korean J Physiol Pharmacol. 2016;20(3):305–314.
  • Thu VT, Kim HK, Long le T, et al. NecroX-5 prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter. Cardiovasc Res. 2012;94(2):342–350.
  • Jahanyar J, Joyce DL, Southard RE, et al. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling. J Heart Lung Transplant. 2007;26(1):34–40.
  • Nagaraju CK, Dries E, Popovic N, et al. Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction. Sci Rep. 2017;7(1):10801.
  • Thu VT, Kim HK, Long le T, et al. NecroX-5 protects mitochondrial oxidative phosphorylation capacity and preserves PGC1alpha expression levels during hypoxia/reoxygenation injury. Korean J Physiol Pharmacol. 2016;20(2):201–211.
  • Buraschi S, Neill T, Goyal A, et al. Decorin causes autophagy in endothelial cells via Peg3. Proc Natl Acad Sci USA. 2013;110(28):E2582–E2591.
  • Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993;72(19):13G–21G.
  • Li L, Okada H, Takemura G, et al. Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction. Am J Physiol Heart Circ Physiol. 2009;297(4):H1504–H1513.
  • Bruckner BA, Razeghi P, Stetson S, et al. Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant. 2004;23(1):36–42.
  • Bruckner BA, Stetson SJ, Perez-Verdia A, et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant. 2001;20(4):457–464.
  • Zimmerman SD, Thomas DP, Velleman SG, et al. Time course of collagen and decorin changes in rat cardiac and skeletal muscle post-MI. Am J Physiol Heart Circ Physiol. 2001;281(4):H1816–H1822.
  • Järvinen TA, Ruoslahti E. Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice. Proc Natl Acad Sci USA. 2010;107(50):21671–21676.
  • Deten A, Hölzl A, Leicht M, et al. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol. 2001;33(6):1191–1207.
  • Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab. 2000;71(1–2):418–435.
  • Kuwahara F, Kai H, Tokuda K, et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation. 2002;106(1):130–135.
  • Ma M, Watanabe K, Wahed MI, et al. Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril. J Cardiovasc Pharmacol. 2001;38(Suppl 1):S51–S54.
  • Giri SN, Hyde DM, Braun RK, et al. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol. 1997;54(11):1205–1216.
  • Hao J, Ju H, Zhao S, et al. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol. 1999;31(3):667–678.
  • Fischer JW, Kinsella MG, Levkau B, et al. Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arterioscler Thromb Vasc Biol. 2001;21(5):777–784.
  • Faust SM, Lu G, Wood SC, et al. TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection. J Immunol. 2009;183(11):7307–7313.
  • Simkhovich BZ, Marjoram P, Poizat C, et al. Age-related changes of cardiac gene expression following myocardial ischemia/reperfusion. Arch Biochem Biophys. 2003;420(2):268–278.
  • Doi M, Kusachi S, Murakami T, et al. Time-dependent changes of decorin in the infarct zone after experimentally induced myocardial infarction in rats: comparison with biglycan. Pathol Res Pract. 2000;196(1):23–33.
  • Burlew BS, Weber KT. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin. 2000;18(3):435–442.
  • Jalil JE, Doering CW, Janicki JS, et al. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64(6):1041–1050.
  • Ständer M, Naumann U, Wick W, et al. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res. 1999;296(2):221–227.
  • Groeneveld TW, Oroszlán M, Owens RT, et al. Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J Immunol. 2005;175(7):4715–4723.
  • Barallobre-Barreiro J, Gupta SK, Zoccarato A, et al. Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation. Circulation. 2016;134(11):817–832.
  • Järvinen TAH. Design of target-seeking antifibrotic compounds. Methods Enzymol. 2012;509:243–261.
  • Medeiros DM, Velleman SG, Jarrold BB, et al. Ontogeny of enhanced decorin levels and distribution within myocardium of failing hearts. Connect Tissue Res. 2002;43(1):32–43.
  • Camara AK, Bienengraeber M, Stowe DF. Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol. 2011;2:13.
  • Crestanello JA, Doliba NM, Babsky AM, et al. Mitochondrial function during ischemic preconditioning. Surgery. 2002;131(2):172–178.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.